Page last updated: 2024-10-28

hexamethylene bisacetamide and Lesch-Nyhan Syndrome

hexamethylene bisacetamide has been researched along with Lesch-Nyhan Syndrome in 1 studies

N,N'-diacetyl-1,6-diaminohexane: chemical name obtained from Acta Biol Hung 1990;41(1-3):199-208

Lesch-Nyhan Syndrome: An inherited disorder transmitted as a sex-linked trait and caused by a deficiency of an enzyme of purine metabolism; HYPOXANTHINE PHOSPHORIBOSYLTRANSFERASE. Affected individuals are normal in the first year of life and then develop psychomotor retardation, extrapyramidal movement disorders, progressive spasticity, and seizures. Self-destructive behaviors such as biting of fingers and lips are seen frequently. Intellectual impairment may also occur but is typically not severe. Elevation of uric acid in the serum leads to the development of renal calculi and gouty arthritis. (Menkes, Textbook of Child Neurology, 5th ed, pp127)

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19901 (100.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Vembu, D1
Young, NS1
Willing, M1
Church, E1
Sanders-Haigh, L1
Anderson, WF1

Other Studies

1 other study available for hexamethylene bisacetamide and Lesch-Nyhan Syndrome

ArticleYear
Regulation of human globin gene expression in mouse erythroleukemia x human fibroblast hybrid cells.
    Somatic cell genetics, 1982, Volume: 8, Issue:2

    Topics: Acetamides; Animals; Antineoplastic Agents; Chelating Agents; Deoxyribonucleases; DNA, Complementary

1982